Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Tess earned her BA in International Relations and Education from Tufts University. After graduation, she taught in Madrid, Spain on Fulbright, and went on to earn her MA in Special Education at CUNY.
Elizabeth is an MD/PhD student at NYU School of Medicine's Medical Scientist Training Program. She holds a BA in Biology with a minor in English from Hunter College.